p.87 抽出テキスト

EVOLVED randomized clinical trial. JAMA 2024;333:213–21. https://doi.org/10.1001/ jama.2024.22730 362. Kang DH, Park SJ, Lee SA, Lee S, Kim DH, Kim HK, et al. Early surgery or conservative care for asymptomatic aortic stenosis. N Engl J Med 2020;382:111–9. https://doi.org/ 10.1056/NEJMoa1912846 363. Banovic M, Putnik S, Penicka M, Doros G, Deja MA, Kockova R, et al. Aortic valve replacement versus conservative treatment in asymptomatic severe aortic stenosis: the AVATAR Trial. Circulation 2022;145:648–58. https://doi.org/10.1161/ CIRCULATIONAHA.121.057639 364. Rosenhek R, Binder T, Porenta G, Lang I, Christ G, Schemper M, et al. Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med 2000;343:611–7. https://doi.org/10.1056/NEJM200008313430903 365. Nakatsuma K, Taniguchi T, Morimoto T, Shiomi H, Ando K, Kanamori N, et al. B-type natriuretic peptide in patients with asymptomatic severe aortic stenosis. Heart 2019; 105:384–90. https://doi.org/10.1136/heartjnl-2018-313746 366. Parikh V, Kim C, Siegel RJ, Arsanjani R, Rader F. Natriuretic peptides for risk stratification of patients with valvular aortic stenosis. Circ Heart Fail 2015;8:373–80. https://doi. org/10.1161/CIRCHEARTFAILURE.114.001649 367. Banovic M, Putnik S, Da Costa BR, Penicka M, Deja MA, Kotrc M, et al. Aortic valve replacement versus conservative treatment in asymptomatic severe aortic stenosis: long-term follow-up of the AVATAR trial. Eur Heart J 2024;45:4526–35. https://doi. org/10.1093/eurheartj/ehae585 368. Généreux P, Banovic M, Kang DH, Giustino G, Prendergast BD, Lindman BR, et al. Aortic valve replacement vs clinical surveillance in asymptomatic severe aortic stenosis: a systematic review and meta-analysis. J Am Coll Cardiol 2024;85:912–22. https://doi. org/10.1016/j.jacc.2024.11.006 369. Smith WTI, Ferguson TBJ, Ryan T, Landolfo CK, Peterson ED. Should coronary artery bypass graft surgery patients with mild or moderate aortic stenosis undergo concomitant aortic valve replacement? A decision analysis approach to the surgical dilemma. J Am Coll Cardiol 2004;44:1241–7. https://doi.org/10.1016/j.jacc.2004.06.031 370. Jean G, Van Mieghem NM, Gegenava T, van Gils L, Bernard J, Geleijnse ML, et al. Moderate aortic stenosis in patients with heart failure and reduced ejection fraction. J Am Coll Cardiol 2021;77:2796–803. https://doi.org/10.1016/j.jacc.2021.04.014 371. Jacquemyn X, Strom JB, Strange G, Playford D, Stewart S, Kutty S, et al. Moderate aortic valve stenosis is associated with increased mortality rate and lifetime loss: systematic review and meta-analysis of reconstructed time-to-event data of 409 680 patients. J Am Heart Assoc 2024;13:e033872. https://doi.org/10.1161/jaha.123.033872 372. Amanullah MR, Pio SM, Ng ACT, Sin KYK, Marsan NA, Ding ZP, et al. Prognostic implications of associated cardiac abnormalities detected on echocardiography in patients with moderate aortic stenosis. JACC Cardiovasc Imaging 2021;14:1724–37. https://doi.org/10.1016/j.jcmg.2021.04.009 373. Van Mieghem NM, Elmariah S, Spitzer E, Pibarot P, Nazif TM, Bax JJ, et al. Transcatheter aortic valve replacement in patients with systolic heart failure and moderate aortic stenosis: TAVR UNLOAD. J Am Coll Cardiol 2024;85:878–90. https://doi. org/10.1016/j.jacc.2024.10.070 374. Graversen PL, Butt JH, Østergaard L, Jensen AD, Warming PE, Strange JE, et al. Changes in aortic valve replacement procedures in Denmark from 2008 to 2020. Heart 2023;109:557–63. https://doi.org/10.1136/heartjnl-2022-321594 375. Johnston DR, Soltesz EG, Vakil N, Rajeswaran J, Roselli EE, Sabik JF 3rd, et al. Long-term durability of bioprosthetic aortic valves: implications from 12,569 implants. Ann Thorac Surg 2015;99:1239–47. https://doi.org/10.1016/j.athoracsur.2014.10.070 376. Goldstone AB, Chiu P, Baiocchi M, Lingala B, Patrick WL, Fischbein MP, et al. Mechanical or biologic prostheses for aortic-valve and mitral-valve replacement. N Engl J Med 2017;377:1847–57. https://doi.org/10.1056/NEJMoa1613792 377. Mazine A, David TE, Stoklosa K, Chung J, Lafreniere-Roula M, Ouzounian M. Improved outcomes following the Ross procedure compared with bioprosthetic aortic valve replacement. J Am Coll Cardiol 2022;79:993–1005. https://doi.org/10.1016/j.jacc.2021.12. 026 378. Notenboom ML, Melina G, Veen KM, De Robertis F, Coppola G, De Siena P, et al. Long-term clinical and echocardiographic outcomes following the Ross procedure: a post hoc analysis of a randomized clinical trial. JAMA Cardiology 2023;9:6–14. https:// doi.org/10.1001/jamacardio.2023.4090 379. Alkhouli M, Zack CJ, Sarraf M, Bashir R, Nishimura RA, Eleid MF, et al. Morbidity and mortality associated with balloon aortic valvuloplasty: a national perspective. Circ Cardiovasc Interv 2017;10:e004481. https://doi.org/10.1161/CIRCINTERVENTIONS. 116.004481 380. Sharma T, Krishnan AM, Lahoud R, Polomsky M, Dauerman HL. National trends in TAVR and SAVR for patients with severe isolated aortic stenosis. J Am Coll Cardiol 2022;80:2054–6. https://doi.org/10.1016/j.jacc.2022.08.787 381. Gaede L, Blumenstein J, Eckel C, Grothusen C, Tiyerili V, Sötemann D, et al. Transcatheter-based aortic valve replacement vs. isolated surgical aortic valve replacement in 2020. Clin Res Cardiol 2022;111:924–33. https://doi.org/10.1007/s00392-022- 02006-1 382. Nguyen V, Willner N, Eltchaninoff H, Burwash IG, Michel M, Durand E, et al. Trends in aortic valve replacement for aortic stenosis: a French nationwide study. Eur Heart J 2022;43:666–79. https://doi.org/10.1093/eurheartj/ehab773 383. Mori M, Gupta A, Wang Y, Vahl T, Nazif T, Kirtane AJ, et al. Trends in transcatheter and surgical aortic valve replacement among older adults in the United States. J Am Coll Cardiol 2021;78:2161–72. https://doi.org/10.1016/j.jacc.2021.09.855 384. Pilgrim T, Windecker S. Expansion of transcatheter aortic valve implantation: new indications and socio-economic considerations. Eur Heart J 2018;39:2643–45. https:// doi.org/10.1093/eurheartj/ehy228 385. Durko AP, Osnabrugge RL, Van Mieghem NM, Milojevic M, Mylotte D, Nkomo VT, et al. Annual number of candidates for transcatheter aortic valve implantation per country: current estimates and future projections. Eur Heart J 2018;39:2635–42. https://doi.org/10.1093/eurheartj/ehy107 386. Barbato E, Noc M, Baumbach A, Dudek D, Bunc M, Skalidis E, et al. Mapping interventional cardiology in Europe: the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Atlas project. Eur Heart J 2020;41:2579–88. https://doi.org/10. 1093/eurheartj/ehaa475 387. Benfari G, Essayagh B, Michelena HI, Ye Z, Inojosa JM, Ribichini FL, et al. Severe aortic stenosis: secular trends of incidence and outcomes. Eur Heart J 2024;45:1877–86. https://doi.org/10.1093/eurheartj/ehad887 388. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363:1597–607. https://doi.org/10.1056/NEJMoa1008232 389. Gleason TG, Reardon MJ, Popma JJ, Deeb GM, Yakubov SJ, Lee JS, et al. 5-Year outcomes of self-expanding transcatheter versus surgical aortic valve replacement in highrisk patients. J Am Coll Cardiol 2018;72:2687–96. https://doi.org/10.1016/j.jacc.2018.08. 2146 390. Mack MJ, Leon MB, Smith CR, Miller DC, Moses JW, Tuzcu EM, et al. 5-Year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 2015;385:2477–84. https://doi.org/10.1016/S0140-6736(15)60308-7 391. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011;364: 2187–98. https://doi.org/10.1056/NEJMoa1103510 392. Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med 2016; 374:1609–20. https://doi.org/10.1056/NEJMoa1514616 393. Toff WD, Hildick-Smith D, Kovac J, Mullen MJ, Wendler O, Mansouri A, et al. Effect of transcatheter aortic valve implantation vs surgical aortic valve replacement on all-cause mortality in patients with aortic stenosis: a randomized clinical trial. JAMA 2022;327: 1875–87. https://doi.org/10.1001/jama.2022.5776 394. Popma JJ, Deeb GM, Yakubov SJ, Mumtaz M, Gada H, O’Hair D, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med 2019;380:1706–15. https://doi.org/10.1056/NEJMoa1816885 395. Blankenberg S, Seiffert M, Vonthein R, Baumgartner H, Bleiziffer S, Borger MA, et al. Transcatheter or surgical treatment of aortic-valve stenosis. N Engl J Med 2024;390: 1572–83. https://doi.org/10.1056/NEJMoa2400685 396. Makkar RR, Thourani VH, Mack MJ, Kodali SK, Kapadia S, Webb JG, et al. Five-year outcomes of transcatheter or surgical aortic-valve replacement. N Engl J Med 2020;382: 799–809. https://doi.org/10.1056/NEJMoa1910555 397. Van Mieghem NM, Deeb GM, Søndergaard L, Grube E, Windecker S, Gada H, et al. Self-expanding transcatheter vs surgical aortic valve replacement in intermediate-risk patients: 5-year outcomes of the SURTAVI randomized clinical trial. JAMA Cardiol 2022;7:1000–8. https://doi.org/10.1001/jamacardio.2022.2695 398. Thyregod HGH, Jørgensen TH, Ihlemann N, Steinbrüchel DA, Nissen H, Kjeldsen BJ, et al. Transcatheter or surgical aortic valve implantation: 10-year outcomes of the NOTION trial. Eur Heart J 2024;45:1116–24. https://doi.org/10.1093/eurheartj/ ehae043 399. Ahmad Y, Howard JP, Arnold AD, Madhavan MV, Cook CM, Alu M, et al. Transcatheter versus surgical aortic valve replacement in lower-risk and higher-risk patients: a meta-analysis of randomized trials. Eur Heart J 2023;44:836–52. https://doi. org/10.1093/eurheartj/ehac642 400. Barili F, Brophy JM, Ronco D, Myers PO, Uva MS, Almeida RMS, et al. Risk of bias in randomized clinical trials comparing transcatheter and surgical aortic valve replacement: a systematic review and meta-analysis. JAMA Netw Open 2023;6:e2249321. https://doi.org/10.1001/jamanetworkopen.2022.49321 401. Siontis GCM, Overtchouk P, Cahill TJ, Modine T, Prendergast B, Praz F, et al. Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: an updated meta-analysis. Eur Heart J 2019;40:3143–53. https://doi.org/10.1093/eurheartj/ehz275 402. Pibarot P, Hahn RT, Weissman NJ, Arsenault M, Beaudoin J, Bernier M, et al. Association of paravalvular regurgitation with 1-year outcomes after transcatheter aortic valve replacement with the SAPIEN 3 valve. JAMA Cardiol 2017;2:1208–16. https://doi.org/10.1001/jamacardio.2017.3425 403. Kodali S, Pibarot P, Douglas PS, Williams M, Xu K, Thourani V, et al. Paravalvular regurgitation after transcatheter aortic valve replacement with the Edwards sapien valve in the PARTNER trial: characterizing patients and impact on outcomes. Eur Heart J 2015;36:449–56. https://doi.org/10.1093/eurheartj/ehu384

ESC Guidelines                                                                                                                                                                                          4721

Downloaded from academic.oup.com/eurheartj/article/46/44/4635/8234488 by guest on 07 October 2026